Evidence map›Paper›PMID 35528341›Full record

ArticleComputational intelligence and neuroscience2022

Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method.

Wahidul Hasan Abir, Md Fahim Uddin, Faria Rahman Khanam, Tahia Tazin, Mohammad Monirujjaman Khan, Mehedi Masud, Sultan Aljahdali

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Biomedical Diagnosis of Leukemia Using a Deep Learner Classifier.Computational intelligence and neuroscience · 2022
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Wahidul Hasan AbirDepartment of Electrical and Computer Engineering, North South University, Bashundhara, Dhaka-1229, Bangladesh.ORCID https://orcid.org/0000-0002-0281-7845
Md Fahim UddinDepartment of Electrical and Computer Engineering, North South University, Bashundhara, Dhaka-1229, Bangladesh.ORCID https://orcid.org/0000-0002-1263-4479
Faria Rahman KhanamDepartment of Electrical and Computer Engineering, North South University, Bashundhara, Dhaka-1229, Bangladesh.ORCID https://orcid.org/0000-0002-8067-8107
Tahia TazinDepartment of Electrical and Computer Engineering, North South University, Bashundhara, Dhaka-1229, Bangladesh.
Mohammad Monirujjaman KhanDepartment of Electrical and Computer Engineering, North South University, Bashundhara, Dhaka-1229, Bangladesh.ORCID https://orcid.org/0000-0003-0779-8820
Mehedi MasudDepartment of Computer Science, College of Computers and Information Technology, Taif University, P. O. Box 11099, Taif 21944, Saudi Arabia.ORCID https://orcid.org/0000-0001-6019-7245
Sultan AljahdaliDepartment of Computer Science, College of Computers and Information Technology, Taif University, P. O. Box 11099, Taif 21944, Saudi Arabia.ORCID https://orcid.org/0000-0003-2615-8271
North South University · BDTaif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

White blood cells (WBCs) are blood cells that fight infections and diseases as a part of the immune system. They are also known as "defender cells." But the imbalance in the number of WBCs in the blood can be hazardous. Leukemia is the most common blood cancer caused by an overabundance of WBCs in the immune system. Acute lymphocytic leukemia (ALL) usually occurs when the bone marrow creates many immature WBCs that destroy healthy cells. People of all ages, including children and adolescents, can be affected by ALL. The rapid proliferation of atypical lymphocyte cells can cause a reduction in new blood cells and increase the chances of death in patients. Therefore, early and precise cancer detection can help with better therapy and a higher survival probability in the case of leukemia. However, diagnosing ALL is time-consuming and complicated, and manual analysis is expensive, with subjective and error-prone outcomes. Thus, detecting normal and malignant cells reliably and accurately is crucial. For this reason, automatic detection using computer-aided diagnostic models can help doctors effectively detect early leukemia. The entire approach may be automated using image processing techniques, reducing physicians' workload and increasing diagnosis accuracy. The impact of deep learning (DL) on medical research has recently proven quite beneficial, offering new avenues and possibilities in the healthcare domain for diagnostic techniques. However, to make that happen soon in DL, the entire community must overcome the explainability limit. Because of the black box operation's shortcomings in artificial intelligence (AI) models' decisions, there is a lack of liability and trust in the outcomes. But explainable artificial intelligence (XAI) can solve this problem by interpreting the predictions of AI systems. This study emphasizes leukemia, specifically ALL. The proposed strategy recognizes acute lymphoblastic leukemia as an automated procedure that applies different transfer learning models to classify ALL. Hence, using local interpretable model-agnostic explanations (LIME) to assure validity and reliability, this method also explains the cause of a specific classification. The proposed method achieved 98.38% accuracy with the InceptionV3 model. Experimental results were found between different transfer learning methods, including ResNet101V2, VGG19, and InceptionResNetV2, later verified with the LIME algorithm for XAI, where the proposed method performed the best. The obtained results and their reliability demonstrate that it can be preferred in identifying ALL, which will assist medical examiners.

Indexed as

Artificial IntelligenceLeukemiaAdolescentChildHumansImage Processing, Computer-AssistedMachine LearningReproducibility of Results

Identifiers

PMID35528341
PMCPMC9068323
OpenAlexW4224985733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.